REDUCTION IN THYMOMA SIZE AFTER PITUITARY SURGERY FOR GROWTH HORMONE SECRETING TUMOR. Hema Padmanabhan, M.D, FACP, FACE
|
|
- Shannon Norman
- 5 years ago
- Views:
Transcription
1 AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset and finalized. This version of the manuscript will be replaced with the final, published version after it has been published in the print edition of the journal. The final, published version may differ from this proof. Case Report ACCR REDUCTION IN THYMOMA SIZE AFTER PITUITARY SURGERY FOR GROWTH HORMONE SECRETING TUMOR Hema Padmanabhan, M.D, FACP, FACE From: Medical Center Navicent Health Running title: Thymoma,a trophic effect of growth hormone in acromegaly Corresponding address: Dr. Hema Padmanabhan Endocrinologist (locum) Medical Center Navicent Health 777 Hemlock St Macon, GA
2 ABSTRACT Objective: A thymoma is a rare tumor of anterior mediastinum and may be under the control of prolactin and growth hormone (GH), as well as GH IGF1 mediated paracrine and autocrine pathways. Methods: Case Report Results: The following case report highlights the unexpected outcome in a mediastinal thymoma after pituitary surgery for a growth hormone producing macroadenoma. A 58 year-old Caucasian man with history of acromegaly caused by a pituitary macroadenoma was also known to have a mediastinal thymoma (proven by biopsy). The thymoma was being monitored by annual imaging studies, as patient was asymptomatic and had declined surgery. The octreotide scan was negative and tests ruled out a growth hormome releasing hormone (GH RH) producing tumor. He underwent transphenoidal surgery for removal of pituitary tumor. After surgery, his insulin growth factor1 (IGF) levels normalized and there was adequate suppression of GH by oral glucose tolerance test (OGTT). Follow up imaging after 6 weeks and 10 months of surgery showed absence of pituitary tumor and marked reduction in size of the mediastinal thymoma. Conclusion: In a patient with acromegaly and thymoma, the surgical treatment of the GH producing tumor might be expected to cause reduction in thymoma size. Therefore, such tumors in patients with acromegaly may simply be monitored clinically. Abbreviations: GH = Growth Hormone; GHRH = Growth Hormone Releasing Hormone; OGTT = Oral Glucose Tolerance Test; IGF1 = Insulin Growth Factor 1; CT = Computed Tomography; MRI = Magnetic Resonance Imaging; CTS = Carpel Tunnel Syndrome; TEC = Thymocyte Epithelial Cell.
3 INTRODUCTION Acromegaly is characterized by excessive secretion of growth hormone (GH) and is usually caused by a GH-secreting pituitary adenoma [1]. Rarely, carcinoid and pancreatic islet cell tumors produce growth hormone- releasing hormone (GH-RH) and may cause excessive GH secretion [2, 3, and 4]. Acromegaly is frequently diagnosed after many years of active GH hypersecretion and causes significant morbidity and mortality due to cardiac, pulmonary and musculoskeletal changes[5].measurement of elevated plasma insulin like growth factor 1 (IGF1) is the single best screening test to make the diagnosis. Treatment is directed at preventing local complications of the tumor mass as well as normalizing GH secretion. Although complete surgical resection of these tumors provides lasting remission, incompletely removed tumors may be adequately treated using long acting somatostatin analogs [6]. Thymomas are rare tumors which usually develop in the chest. Although confirmatory diagnosis relies on guided-biopsy, computerized tomography (CT) alone or in combination with magnetic resonance imaging (MRI) provides important information regarding the extent of the tumor, its boundaries with adjacent organs, the choice of the appropriate therapeutic option and the assessment of response to treatment. More recently radiopharmaceuticals and nuclear imaging procedures have been used increasingly employed in the functional characterization of benign and malignant thymic disorders [7]. The following case illustrates a marked reduction in size of a mediastinal thymoma after surgical removal of growth hormone producing pituitary tumor. CASE REPORT A 60 year old Caucasian man with history of obstructive sleep apnea (OSAP), renal calculi, generalized osteoarthritis and colon cancer (status post surgery and chemotherapy in 2000) was referred for evaluation of secondary hypogonadism. His phenotypic features, typical of acromegaly (frontal bossing, broad nose, large tongue, increased spacing of teeth, prognathism, large spade like hands and large feet), prompted a work-up for the disease. He had noted increase in shoe size from 9 to 12 between 1969 to 2004, had carpel tunnel syndrome (CTS) surgery of left hand in 1985, and active CTS involving the right hand. He had noted sinus congestion and
4 headaches 2-3 /week with a subjective intensity of 4/10. The pain was located at the center and front of his head. He had no double vision, and objective evaluation showed no deficits in peripheral vision. He had gained 70 lbs in the preceding 20 years and noted increase in tongue size over the past 10 years. He had no symptoms of diabetes insipidus or diabetes mellitus. His energy level was low but he had no symptoms of erectile dysfunction. He had a history of 3.73x3.8cm mediastinal thymoma (figure 1: A, B) which was proven by biopsy in The thymoma was being monitored by periodic imaging as patient was asymptomatic and had declined surgery. The tissue did not stain for GH. Additional staining done for immunohistochemical markers ( chromogrannin, synaptophysin, neuron specific enolase and calcitonin) were also negative.these special studies were carried out after a diagnosis of acromegaly was made, due to possibility of a GHRH or GH producing ectopic tumor (e.g. thymoma). The pathologist reiterated the diagnosis of thymoma after repeat review of slides. Family history was negative for kidney disease or pituitary tumors. He was married and had 2 children age 35 and 37. He quit smoking (after 20 yrs) in 2000, and drank 12 beers a year. He had no history of illicit drug use. Physical examination Weight lbs, Heart rate 54, BP 157/76. He had coarse facial features, macroglossia, prognathism, malocclusion, a broad nose and lips. His thyroid was enlarged on the right side. He had large hands and feet, with moist palms. He had skin tags under his arm and right chest. The remainder of the physical examination revealed normal respiratory, cardiac, abdominal and neurological systems. His initial IGF1 was 954 ng/ml (75-212) in 2007, and remained high on subsequent labs. In Feb 2009, his IGF1 was 1005 ng/ml. GH was high. An oral GTT showed non suppression of GH. The fasting and peak plasma glucose were 73mg/dl and 123mg/dl respectively. The corresponding growth hormone (GH) values were 0.26ng/ml and 0.98ng/ml respectively. The GH nadir was 0.23ng/ml.
5 His free thyroxine, and serum free and total testosterone were within normal range. He was not screened for cortisol deficiency or excess. MRI of the pituitary showed a 6.5x 8.9x 11mm pituitary macroadenoma (initial MRI done as open modality did not reveal a clear cut tumor). The GHRH level was normal thus excluding a GHRH producing ectopic tumor (e.g. carcinoid). Patient, however, declined to undergo pituitary surgery As he had declined surgery, and the IGF1 levels was progressively rising he was started on Lanreotide (Somatuline, Tercica Pharmaceuticals) in February 2009 at a dose of 90mg administered every 28 days by deep subcutaneous route. On this dose the IGF1 decreased from 1005 to 462 ng/ml in July 09, but increased to 832 ng/ml in September 09. The dose of Lanreotide was increased to 120mg which he received in September and December Patient was advised to have surgery since the IGF 1 was persistently elevated despite one year treatment with Somatuline. He consented to undergo transphenoidal surgery. Preoperative IGF 796( ng/ml), GH 2.62( ng/ml), Serum Osmolality 298 mosm/kg( ), Intact PTH 78.4( 12-65) pg/ml, prolactin 6.6( <20 ng/ml), cortisol 6.3 ug/dl, free T4 1.2 ng /dl ( ng/dl), LH 1.0 miu/ml He had transphenoidal surgery on 2/18/10. The tumor was immediately evident in the anterior portion of the gland. There was no pseudo capsule; therefore the tumor was internally debulked until a gross total resection had been accomplished. There was no evidence of invasion of either cavernous sinus and no intraoperative spinal fluid leak. Post operative period was uneventful and patient was discharged 48 hours later. Histopathology revealed a tumor composed of small cells with eosinophilic cytoplasm and occasional nucleoli. A reticulin stain confirms the loss of acinar architecture within the tumor and highlights focally entrapped normal ant pituitary gland. A panel of immunohistochemical stains revealed the tumor to be strongly positive for GH and prolactin.
6 After the surgery, the IGF 1 value normalized and OGTT showed normal suppression of GH. Follow up MRI of pituitary with gadolinium (at 6weeks) showed post operative changes without evidence of residual tumor. Chest CT scan showed marked reduction in size of the mediastinal thymoma after surgery, from 3.73x3.8cm to 3.1x2.9cm (Figure 1: C, D). The volume of tumor could not be calculated as there were only two measurements available. The finding remained stable 10 months after surgery. DISCUSSION There was significant reduction in thymoma size after removal of the pituitary tumor which might suggest trophic effects of growth hormone on thymic tissue either directly or via IGF1. There is increasing evidence that GH can influence immune functions and that it is secreted by lymphocytes. Further, GH functions as an autocrine/paracrine growth factor in the human thymus via locally synthesized IGF-1[8]. Increasing evidence has placed hormones and neuropeptides among potent immunomodulators, in both health and disease. Exogenous GH enhances thymic microenvironmental cell-derived secretory products such as cytokines and thymic hormones. Moreover, GH increases thymic epithelial cell (TEC) proliferation in vitro and exhibits a synergistic effect with anti CD3 in stimulating thymocyte proliferation, which is in keeping with the data showing that transgenic mice over expressing GH or GH releasing hormone exhibit overgrowth of the thymus [9] by IGF1 production and expression of IGF1 by TEC and thymocytes. There is an intrathymic circuitry involving not only IGF1 but also GH itself as intrathymic GH expression is seen in both TEC and thymocyte. Thymocyte derived GH could enhance thymocyte proliferation. Finally the possibility that GH improves thymic functions including thymocyte proliferation and migration, places this molecule as a potential therapeutic adjuvant in immunodefiency conditions associated with thymocyte decrease and loss of peripheral T cells. GH could directly or indirectly induce proliferation of TECs and thus might be related to formation of epithelial thymic rudiment in the fetal stage [10]. CONCLUSION
7 This case report illustrates the possible relationship between growth hormone producing pituitary tumor and thymoma. Size reduction was observed after successful pituitary tumor removal in this patient.mediastinal thymomas in patients with acromegaly (due to GH producing pituitary tumor) may be monitored if patient is asymptomatic. There is a possibility of its resolution with removal of the pituitary tumor thus preventing unnecessary thymic surgery and its attendant risks. We were not expecting any notable change in the size of the thymoma and were mainly focused on management of acromegaly. Therefore, we did not do serial imaging of the thymoma or IGF1 levels at various intervals during the phase of medical management of acromegaly. ACKNOWLEDGMENT I managed this patient while working as staff endocrinologist in VA Medical Center, Salem, VA ( ). I am grateful to Dr Michael Thorner, MBBS, DSc, Division of Endocrinology, University of Charlottesville, VA for assistance in managing the case. REFERENCES 1. Melmed S, Braunstein GD, Horvath E, Ezrin C,Kovacs K. Pathophysiology of acromegaly. Endocr Rev. 1983; 4: Frohman LA, Szabo M, Berelowitz M, Stachura ME. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest.1980; 65: Thorner MO, Perryman RL, Cronin MJ, et al. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormonereleasing factor.j Clin Invest.1982; 70: Guillemin R, Brazeau P, Bohlen P, et al. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science.1982; 218:
8 5. Jaffe CA, Barkan AL. Acromegaly: Recognition and treatment. Drugs. 1994; 47: Melmed S, Ziel FH, Braunstein GD, Downs T, Frohman LA. Medical management of acromegaly due to ectopic production of GHRH by a carcinoid tumor. J Clin Endocrinol Metab.1988; 67: Lastoria S, Palmieri G, Muto P, Lombardi G. Functional imaging of thymic disorders. Ann Med. Oct: 1999; 31 Suppl 2: Sabharwal P, Varma S. Growth hormone synthesized and secreted by human thymocytes acts via insulin like growth factor 1 as an autocrine and paracrine growth factor. J Clin Endocrinol Metab.1996; 81: Savino W, Postel-Vinay MC, Smaniotto S, Dardenne.The thymus gland: a target for growth hormone. M. Scand J immunol. 2002; 55; Tsuji Y, Kinoshita Y, Hato F, Tominaga K, Yoshida K.The invitro proliferation of thymus epithelial cells stimulated with growth hormone and insulin-like growth factor -1. Cell Mol Bio.1994;l40:
9 A B C D
Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)
Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland. In patients
More informationHigh and Low GH: an update of diagnosis and management of GH disorders
High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education
More informationPituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17
Pituitary Adenomas: Evaluation and Management Fawn M. Wolf, MD 10/27/17 Over 18,000 pituitaries examined at autopsy: -10.6% contained adenomas (1.5-27%) -Frequency similar for men and women and across
More informationTreating a Growing Problem: A Closer Look at Acromegaly. Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD
Treating a Growing Problem: A Closer Look at Acromegaly Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD Goal Address key challenges faced by physicians who treat acromegaly
More informationUW MEDICINE PATIENT EDUCATION. Acromegaly Symptoms and treatments. What is acromegaly? DRAFT. What are the symptoms? How is it diagnosed?
UW MEDICINE PATIENT EDUCATION Acromegaly Symptoms and treatments This handout explains a health condition called acromegaly. It describes tests that are used to diagnose the condition and gives basic instructions
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationClinical Policy: Pasireotide (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: 03.01.17 Last Review Date: 11.17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the
More informationInitials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male
1. Patient personal details Institute code: Physician code: Initials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male 2. Changes in acromegaly-specific medical
More informationFunctional Pituitary Adenomas. Fawn M. Wolf, MD 2/2/2018
Functional Pituitary Adenomas Fawn M. Wolf, MD 2/2/2018 Outline Prolactinoma Acromegaly Cushing s disease Thyrotroph adenomas Gonadotroph adenomas Hyperprolactinemia Clinically apparent prolactinomas:
More informationManaging Acromegaly: Review of Two Cases
Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have
More informationCYSTIC PROLACTINOMA: A SURGICAL DISEASE?
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: somatostatin_analogs 7/2016 7/2017 7/2018 7/2017 Description of Procedure or Service Somatostatin, a hypothalamic
More informationClinical Policy: Pasireotide (Signifor LAR) Reference Number: CP.PHAR.332
Clinical Policy: (Signifor LAR) Reference Number: CP.PHAR.332 Effective Date: 03/17 Last Review Date: 02/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationPituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs Shereen Ezzat, MD, FRCP(C), FACP Professor Of Medicine & Oncology Head, Endocrine Oncology Princess Margaret Hospital/University
More informationManaging Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)
Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of
More informationPituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
More information62-year-old woman with severe headache. Celeste Thomas November 1, 2012
62-year-old woman with severe headache Celeste Thomas November 1, 2012 History of Present Illness History of hypertension and hyperlipidemia Presented to outside hospital after awakening from sleep with
More informationImaging pituitary gland tumors
November 2005 Imaging pituitary gland tumors Neel Varshney,, Harvard Medical School Year IV Two categories of presenting signs of a pituitary mass Functional tumors present with symptoms due to excess
More informationGrowth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D.
Growth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D. I. Growth Hormone (somatotropin): Growth hormone (GH) is a 191 amino acid single chain polypeptide (MW 22,000 daltons). Growth
More informationChapter 13 Endocrine System. Endocrine System. Endocrine System Functions
Chapter 13 Endocrine System Endocrine glands are ductless Exocrine glands have ducts 1 Endocrine System composed of cells, tissues and organs that secrete substances into the internal environment Hormones
More informationChapter 13 Endocrine System. Endocrine System. Endocrine Glands. Comparison of Nervous System and Endocrine System
Endocrine glands are ductless Exocrine glands have ducts Chapter 13 Endocrine System 1 Endocrine System composed of cells, tissues and organs that secrete substances into the internal environment Hormones
More informationAcromegaly: a challenging condition to diagnose and manage. C. L. Chik, MD, PhD, FRCPC University of Alberta, Edmonton
Acromegaly: a challenging condition to diagnose and manage C. L. Chik, MD, PhD, FRCPC University of Alberta, Edmonton Acromegaly: a challenging condition to diagnose and manage? Objectives: n Know the
More informationChapter 2 Acromegaly, Awareness Is Paramount for Early Diagnosis: Highlights of Diagnosis and Treatment Challenges
Chapter 2 Acromegaly, Awareness Is Paramount for Early Diagnosis: Highlights of Diagnosis and Treatment Challenges Jessica Brzana, Christine G. Yedinak, and Maria Fleseriu Objectives To highlight clinical
More informationMULTI-SYSTEM SARCOIDOSIS CAUSING PANHYPOPITUITARISM: RAPID IMPROVEMENT WITH CORTICOSTEROID THERAPY Rashid Mahboob, MD; Ali A.
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST
Case Report ACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST Anupa Sharma, DO 1 ; Eric K.Richfield, MD, PhD 2 ; Sara E. Lubitz, MD 1 ABSTRACT
More informationEndocrine Pharmacology
Endocrine Pharmacology 17-2-2013 DRUGS AFFECTING THE ENDOCRINE SYSTEM The endocrine system is the system of glands, each of which secretes a type of hormone directly into the bloodstream to regulate the
More informationHypothalamic & Pituitary Hormones
1 Hypothalamic & Pituitary Hormones Pharmacologic Applications: Drugs that mimic or block the effects of hypothalamic or pituitary hormones have the following applications: 1. Replacement therapy for hormone
More informationWhat we will cover. Evaluation of the Child with Suspected Pituitary Disease. ituitary
Evaluation of the Child with Suspected Pituitary Disease Craig Alter, MD University of Pennsylvania Children s Hospital of Philadelphia What we will cover * What laboratory tests to order * MRI: common
More informationMANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY
Case Report MANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY Murray B. Gordon, MD, FACE; Kellie L. Spiller, MS ABSTRACT Submitted for publication July
More informationTherapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015
Therapeutic Objectives Update on the Management of Lewis S. Blevins, Jr., M.D. Correct the syndrome by lowering daily cortisol secretion to normal Eradicate any tumor that might threaten the health of
More information14 Girl with Cushing s Disease: An Update. Kristen Dillard, MD Endorama October 17, 2013
14 Girl with Cushing s Disease: An Update Kristen Dillard, MD Endorama October 17, 2013 Initial Presentation Pt initially presented to pediatrician for school physical in fall 2012. Pt was found to be
More informationPasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line
Pasireotide Long-Acting Repeatable (Signifor) for acromegaly first and second line December 2010 This technology summary is based on information available at the time of research and a limited literature
More informationPituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist
Pituitary for the General Practitioner Marilyn Lee Consultant physician and endocrinologist Pituitary tumours Anterior/posterior pituitary Extension of adenoma upwards/downwards/sideways Producing too
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More informationIntroduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly
Introduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly Dr. Peter Igaz MD PhD DSc 2nd Department of Medicine Semmelweis University Fields of Endocrinology Diseases
More information(3) Pituitary tumours
Hypopituitarism Diabetes Insipidus Pituitary tumours (2) Dr T Kemp - Endocrinology and Metabolism Unit - Steve Biko Academic Hospital (3) Pituitary tumours Pituitary microadenoma - intrasellar adenoma
More informationENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES:
ENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES: -In a living organism there must be coordination of number of physiological activities taking place simultaneously such as: movement, respiration,
More informationNo cases of precocious puberty were reported during clinical trials of risperidone in, cases of precocious puberty have been
levels than adults. The growth hormone elevations reported for the 12 patients with growth hormone excess were modest and well below levels reported in children with gigantism. 7,8 None of the patients
More informationInappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient with a Pituitary Macroadenoma
114 Lermah S. unoy, et al Inappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient Case Report Inappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient with a Pituitary
More informationAn Unexpected Cause of Hypoglycemia
An Unexpected Cause of Hypoglycemia Stacey A. Milan, MD FACS Surgical Oncology Nothing to disclose Disclosures Objectives Identify indications for workup of hypoglycemia Define work up for hypoglycemic
More informationDiseases of pituitary gland
Diseases of pituitary gland A brief introduction Anterior lobe = adenohypophysis Posterior lobe = neurohypophysis The production of most pituitary hormones is controlled in large part by positively and
More informationAcromegaly Presenting as Diabetic
Acromegaly Presenting as Diabetic Ketoacidosis: Thinking Beyond Diabetes Mellitus Mahmoud Farhoud, M.D., Paul Ndunda, M.D., Justin B. Moore, M.D. University of Kansas School of Medicine-Wichita Department
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationNANOS Patient Brochure
NANOS Patient Brochure Pituitary Tumor Copyright 2015. North American Neuro-Ophthalmology Society. All rights reserved. These brochures are produced and made available as is without warranty and for informational
More informationEndocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part one Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy HORMONES Hormones are chemicals released by a cell or a gland
More informationHormones and the Endocrine System Chapter 45. Intercellular communication. Paracrine and Autocrine Signaling. Signaling by local regulators 11/26/2017
Hormones and the Endocrine System Chapter 45 Intercellular communication Endocrine signaling Local regulators Paracrine and autocrine signaling Neuron signaling Synaptic and neuroendocrine signaling Paracrine
More informationUsefulness of the Thyrotropin-Releasing Hormone Test in Pre-Clinical Acromegaly
Tohoku J. Exp. Med., 2005, 206, 291-297 Pre-Clinical Acromegaly 291 Usefulness of the Thyrotropin-Releasing Hormone Test in Pre-Clinical Acromegaly KAZUNORI KAGEYAMA, TAKAKO MORIYAMA, SATORU SAKIHARA,
More informationTargeted Issues in Endocrinology Joshua S. Coren, DO, MBA, FACOFP
Targeted Issues in Endocrinology Joshua S. Coren, DO, MBA, FACOFP Endocrine in 25 Minutes Joshua S. Coren, D.O., MBA, FACOFP Vice Chair and Associate Professor, Family Medicine Rowan University School
More informationAcromegaly: Management of the Patient Who Has Failed Surgery
Acromegaly: Management of the Patient Who Has Failed Surgery Minnesota/Midwest Chapter of the American Association of Clinical Endocrinologists 8 th Annual Meeting October 14, 2017 Mark E. Molitch, M.D.
More informationBIOM2010 (till mid sem) Endocrinology. e.g. anterior pituitary gland, thyroid, adrenal. Pineal Heart GI Female
BIOM2010 (till mid sem) Endocrinology Endocrine system Endocrine gland : a that acts by directly into the which then to other parts of the body to act on (cells, tissues, organs) : found at e.g. anterior
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationCase Report A Rare Corticotroph-Secreting Tumor with Coexisting Prolactin and Growth Hormone Staining Cells
Case Reports in Endocrinology Volume 2012, Article ID 529730, 5 pages doi:10.1155/2012/529730 Case Report A Rare Corticotroph-Secreting Tumor with Coexisting Prolactin and Growth Hormone Staining Cells
More informationChallenging Pituitary Cases. Laurence Katznelson, MD Professor of Medicine and Neurosurgery Stanford University School of Medicine
Challenging Pituitary Cases Laurence Katznelson, MD Professor of Medicine and Neurosurgery Stanford University School of Medicine 1 34 yo male has incidental finding of large macroadenoma, with prolactin
More informationCase report. Kováčová Martina Comenius University in Bratislava Slovakia Faculty of medicine
Case report Kováčová Martina Comenius University in Bratislava Slovakia Faculty of medicine Past medical history 38 years old male patient No past medical or surgical history prior to presentation No medications
More informationPancreatic Insulinoma Presenting. with Episodes of Hypoinsulinemic. Hypoglycemia in Elderly ---- A Case Report
2008 19 432-436 Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report Chieh-Hsiang Lu 1, Shih-Che Hua 1, and Chung-Jung Wu 2,3 1 Division of Endocrinology
More informationRECURRENT ADRENAL DISEASE. Megan Applewhite Endorama 2/19/2015 SR , SC
RECURRENT ADRENAL DISEASE Megan Applewhite Endorama 2/19/2015 SR 2412318, SC 3421561 Category: Adrenal Attendings: Angelos & Grogan PATIENT #1 36yo woman with a hx of Cushing s Syndrome and right adrenalectomy
More informationJACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY
JACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY JACK L. SNITZER, D.O. Peninsula Regional Endocrinology 1415 S. Division Street Salisbury, MD 21804 Phone:410-572-8848 Fax:410-572-6890
More informationEndocrine System. Endocrine vs. Exocrine. Bio 250 Human Anatomy & Physiology
Endocrine System Bio 250 Human Anatomy & Physiology Endocrine vs. Exocrine Endocrine glands secrete their products called hormones into body fluids (the internal environment) Exocrine glands secrete their
More informationENDOCRINOLOGY. Dr.AZZA SAJID ALKINANY 2 nd STAGE
ENDOCRINOLOGY Dr.AZZA SAJID ALKINANY 2 nd STAGE THE RELATIONSHIP AMONG THE HYPOTHALMUS,POSTERIOR PITUITARY AND TARGET TISSUES. The posterior pituitary does not produce its own hormones, but stores and
More informationCase 2: 30 yr-old woman with 7 yr history of recurrent kidney stones
Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) 30 yr-old woman with 7 yr history
More informationStelios Mantis, MD DuPage Medical Group Pediatric Endocrinology
Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology 4 11 13 Initial Presentation Pt initially presented to pediatrician for school physical in fall 2012. Pt was found to be overweight (BMI:
More informationProlactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)
Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland.
More informationA Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease
A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease Z Hussein, MRCP*, B Tress**, P G Cohnan, FRACP***... 'Department of Medicine, Hospital Putrajaya, Putrajaya, Presint 7, 62250
More informationCertain types of tumors, in the CNS and elsewhere,
clinical article J Neurosurg 122:798 802, 2015 Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly Lucia Schwyzer, MD, Robert M. Starke, MD, John
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference June 7, 2016 NASDAQ: CHMA Forward-Looking Statements These slides contain forward-looking statements and information. The use of words such as may, might, will, should,
More informationBODY CONTROL SYSTEMS
BODY CONTROL SYSTEMS THE ENDOCRINE SYSTEM - 1 of the 2 chemical control systems of the human body - function of the endocrine system: regulate body functions = maintain homeostasis ie. physical and mental
More informationCLINICALLY SILENT ACTH CROOKE S CELL ADENOMA PRESENTING AS UNILATERAL EAR PAIN
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationHormonal regulation of. Physiology Department Medical School, University of Sumatera Utara
Hormonal regulation of nutrient metabolism Physiology Department Medical School, University of Sumatera Utara Homeostasis & Controls Successful compensation Homeostasis reestablished Failure to compensate
More informationEndocrine System Notes
Endocrine System Notes is the tendency to maintain a stable internal environment. - parts of the body that secrete hormones directly into the body. - parts of the body that make secretions which travel
More informationPituitary Disorders Suranut Charoensri, MD
Pituitary Disorders Suranut Charoensri, MD Division of Endocrinology and Metabolism Department of Medicine Faculty of Medicine, Khon Kaen University Anatomical Landmarks Nat Rev Endocrinol 2014;10:423-435
More informationChanging patterns of insulin-like growth factor I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly
J Neurosurg 97:287 292, 2002 Changing patterns of insulin-like growth factor I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly ANA LAURA ESPINOSA-DE-LOS-MONTEROS,
More informationEndocrine Topic Review. Sethanant Sethakarun, MD
Endocrine Topic Review Sethanant Sethakarun, MD Definition Cushing's syndrome comprises a large group of signs and symptoms that reflect prolonged and in appropriately high exposure of tissue to glucocorticoids
More informationSubject Index. hypothalamic-pituitary-adrenal axis 158. Atherosclerosis, ghrelin role AVP, see Arginine vasopressin.
Subject Index Acromegaly, somatostatin analog therapy dopamine agonist combination therapy 132 efficacy 132, 133 overview 130, 131 receptor subtype response 131, 132 SOM30 studies 131, 132 ACTH, see Adrenocorticotropic
More informationLab 14 Endocrine System
Lab 14 Endocrine System Laboratory Objectives Identify the location of the primary endocrine organs. List the hormones produced by the endocrine organs. Relate the mechanisms of up-regulation and down-regulation
More informationHypothalamus & pituitary gland
Hypothalamus & pituitary gland Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C541, Block C, Research Building, School of Medicine Tel: 88208292 Outline Hypothalamus Relationship between the hypothalamus
More informationEndocrine System. Modified by M. Myers
Endocrine System Modified by M. Myers 1 The Endocrine System 2 Endocrine Glands The endocrine system is made of glands & tissues that secrete hormones. Hormones are chemicals messengers influencing a.
More informationSomatostatin Analog and Estrogen Treatment in a Tall Girl
Clin Pediatr Endocrinol 1995; 4 (2): 163-167 Copyright (C) 1995 by The Japanese Society for Pediatric Endocrinology Somatostatin Analog and Estrogen Treatment in a Tall Girl Toshiaki Tanaka, Mari Satoh,
More informationA VIPER IN THE COURTYARD L A I L A ABUZA I D, M D
A VIPER IN THE COURTYARD L A I L A ABUZA I D, M D E N D O C R I N O L O G Y FELLOW NO DISCOLSURES OBJECTIVES: Recognize signs and symptoms of hyperthyroidism Develop a differential diagnosis for a patient
More informationPituitary gland diseases
Pituitary gland diseases Pituitary Gland Weight 600 mg Is located within the sella turcica Anatomically and functionally distinct anterior and posterior lobes Pituitary Development The pituitary originate
More informationAdrenal Glands. Adrenal Glands. Adrenal Glands. Adrenal Glands. Adrenal Glands 4/12/2016. Controlled by both nerves and hormones.
Glands http://www.hawaiilife.com/articles/2012/03/good-news-vacation-rental-owners/ 70 Figure 10.14a gland Glands cortex Mineralocorticoids Gonadocorticoids Glucocorticoids medulla Epinephrine Norepinephrine
More informationBrain Tumors. Andrew J. Fabiano, MD FAANS. Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine
Brain Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases Brain
More informationBrain and Spine Tumors
Brain and Spine Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases
More informationRegula'ng Body Func'on
Chapter 10 Regula'ng Body Func'on Working closely with your nervous system is the endocrine system, a chemical communication system that regulate many body functions. Exocrine vs Endocrine Exocrine Glands
More informationChapter 9 The Endocrine System and Hormone Activity
Chapter 9 The Endocrine System and Hormone Activity Overview Coordinates and directs the activity of cells. Interacts with the nervous system Uses chemical messengers called hormones released by organs
More informationDiagnosing and monitoring NET
Diagnosing and monitoring NET Inaccurate or delayed diagnosis of neuroendocrine tumors (NET) is common, because many NET are small and asymptomatic. 1 When symptoms are present, they are usually nonspecific
More informationSOMATULINE DEPOT (lanreotide acetate)
SOMATULINE DEPOT (lanreotide acetate) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical
More informationChapter 20. Endocrine System Chemical signals coordinate body functions Chemical signals coordinate body functions. !
26.1 Chemical signals coordinate body functions Chapter 20 Endocrine System! Hormones Chemical signals Secreted by endocrine glands Usually carried in the blood Cause specific changes in target cells Secretory
More informationTHE ANTERIOR PITUITARY. Embryology cont. Embryology of the pituitary BY MISPA ZUH HS09A179. Embryology cont. THE PITUIYARY GLAND Anatomy:
THE ANTERIOR PITUITARY BY MISPA ZUH HS09A179 Embryology of the pituitary The pituitary is formed early in embryonic life from the fusion of the Rathke s pouch (anterior) and the diencephalon ( posterior)
More informationAccepted Manuscript. Pituitary metastasis of breast cancer mimicking IgG4-related hypophysitis
Accepted Manuscript Pituitary metastasis of breast cancer mimicking IgG4-related hypophysitis Kanako Nose, Toshiyasu Ogata, Jun Tsugawa, Tooru Inoue, Kazuki Nabeshima, Yoshio Tsuboi PII: S2405-6502(18)30046-7
More informationEndocrine Glands and Hormones "What are endocrine glands and what do they make?
Endocrine Glands and Hormones "What are endocrine glands and what do they make? Model 1:Development of glands. Exocrine Gland Endocrine Gland Critical thinking questions 1. Based on the model, which of
More informationPathology of pituitary gland. By: Shifaa Qa qa
Pathology of pituitary gland By: Shifaa Qa qa Sella turcica Adenohypophysis (80%): - epithelial cells - acidophil, basophil, chromophobe - Somatotrophs, Mammosomatotrophs, Corticotrophs, Thyrotrophs, Gonadotrophs
More informationCost-Effectiveness of Somatostatin Analogues for the Treatment of Acromegaly in Colombia
Open Journal of Endocrine and Metabolic Diseases, 2012, 2, 102-106 http://dx.doi.org/10.4236/ojemd.2012.24016 Published Online November 2012 (http://www.scirp.org/journal/ojemd) Cost-Effectiveness of Somatostatin
More informationTreating Cystic Prolactinomas with Dopamine Agonists: Partial Cabergoline Resistance and Considering Dose Reduction
Treating Cystic Prolactinomas with Dopamine Agonists: Partial Cabergoline Resistance and Considering Dose Reduction Mohammad Talha Rauf, MD Internal Medicine Resident PGY3 Dania AbuShanab, MD Julie Samantray,
More informationPharmacy Prior Authorization Somatostatin Analogs Clinical Guideline
Sandostatin LAR (octreotide) Signifor (pasireotide) Signifor LAR (pasireotide) Somatuline Depot (lanreotide) octreotide FDA Approved Indications: Acromegaly: Octreotide Injection is indicated to reduce
More informationPituitary Gland Disorders
Pituitary Gland Disorders 1 2 (GH-RH) (CRH) (TRH) (TRH) (GTRH) (GTRH) 3 Classification of pituitary disorders: 1. Hypersecretory diseases: a. Acromegaly and gigantism: Usually caused by (GH)-secreting
More informationImaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman
Imaging The Turkish Saddle Russell Goodman, HMS III Dr. Gillian Lieberman Learning Objectives Review the anatomy of the sellar region Discuss the differential diagnosis of sellar masses Discuss typical
More informationAbstract. Introduction
Clinical Features and Outcome of Surgery in 30 Patients with Acromegaly A. Chandna, N. Islam, A. Jabbar, L. Zuberi, N. Haque Endocrinology Section, Department of Medicine, Aga Khan University Hospital,
More informationResult Navigator. Positive Test Result: MEN1. After a positive test result, there can be many questions about what to do next. Navigate Your Results
Result Navigator Positive Test Result: MEN1 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life
More informationEndocrine secretion cells secrete substances into the extracellular fluid
Animal Hormones Concept 30.1 Hormones Are Chemical Messengers Endocrine secretion cells secrete substances into the extracellular fluid Exocrine secretion cells secrete substances into a duct or a body
More information66 M with erectile dysfunction and abnormal labs RAJESH JAIN ENDORAMA 10/29/2015
66 M with erectile dysfunction and abnormal labs RAJESH JAIN ENDORAMA 10/29/2015 HPI 66 M presenting as a referral for erectile dysfunction and abnormal labs Has been seeing a facility specializing in
More information